granisetron has been researched along with Anankastic Personality in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eftekhar Ardebili, M; Ghobadian, A; Kamalzadeh, L; Mokhtari, S; Shalbafan, M; Shariati, B; Shati, M; Yarahmadi, M | 1 |
| Maiti, R; Mishra, A; Mishra, BR; Srinivasan, A | 1 |
| Abdolrazaghnejad, A; Aghakarim Alamdar, M; Ebrahimi-Monfared, M; Massoudifar, A; Mohammadbeigi, A; Saber, R; Sharafkhah, M | 1 |
| Akhondzadeh, S; Ashrafi, M; Askari, N; Hajiaghaee, R; Hosseini, SM; Modabbernia, A; Moin, M; Najand, B; Salimi, S; Sanati, M; Tabrizi, M; Tajdini, M | 1 |
1 review(s) available for granisetron and Anankastic Personality
| Article | Year |
|---|---|
Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
Topics: Bayes Theorem; Drug Therapy, Combination; Granisetron; Humans; Lamotrigine; Memantine; Network Meta-Analysis; Obsessive-Compulsive Disorder; Ondansetron; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2023 |
3 trial(s) available for granisetron and Anankastic Personality
| Article | Year |
|---|---|
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
Topics: Double-Blind Method; Drug Therapy, Combination; Granisetron; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Treatment Outcome | 2022 |
Comparing the efficacy of ondansetron and granisetron augmentation in treatment-resistant obsessive-compulsive disorder: a randomized double-blind placebo-controlled study.
Topics: Double-Blind Method; Granisetron; Obsessive-Compulsive Disorder; Ondansetron; Serotonin Antagonists | 2019 |
Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Granisetron; Humans; Male; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Serotonin 5-HT3 Receptor Antagonists | 2012 |